Le Lézard
Classified in: Health
Subjects: FDA, PLW, MAT

A New Cannabis Drug Delivery Technology Capable of Meeting FDA Requirement For Delivery of Cannabinoid Formulations in Vapor Form


Enabling Medicaments for: PTSD, Alzheimer's, Chronic pain, Cancer and much more

STILLWATER, Minn., Aug. 29, 2022 /PRNewswire/ -- Vapor Cartridge Technology LLC, based in Stillwater Minnesota, has invented and patented a groundbreaking technology that portends the power to truly change the entire medical cannabis industry. Vapor Cartridge Technology LLC has invented and patented an FDA approvable environmentally friendly cost-effective process, for extracting the essential oils/resins from botanical plants (e.g., cannabis) and an FDA approvable device for delivering a pure and exact dose of the extracted oils/resins as a consistently reliable precise inhalable vapor.

It promises to be, far and away, the most cost-efficient manner to deliver cannabinoid vapors as measured by $/mg/ml of cannabinoids in the bloodstream. It promises to be the only technology that can provide the dose control, formulation control and purity assurance of inhaled botanical vapors required of an FDA approved drug. This technology will result in a paradigm shift in both the Medical and Recreational cannabis markets.

"Once commercialized The Vapor Cartridge Technology will quickly become the medical standard for ingesting cannabinoid drugs in vapor form" according to a spokesperson for the company.

Vapor Cartridge Technology LLC is currently seeking licensing opportunities for their new technology and have launched data rich website (https://vaporcartridgetechnology.com) towards this objective. The compelling website contains a detailed explanation of the science behind the technology, a competitive analysis, the benefits of the technology, the patent portfolio, potential licensees, and a way to contact the company.

Media Contact:

Timothy McCullough
6514912115
[email protected]

SOURCE Vapor Cartridge Technology LLC


These press releases may also interest you

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to...

at 02:00
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study.  Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital,...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the quarter ending March 31, 2024. "We are executing our strategy of building on our partnered...

at 00:01
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today debuted the Best Ambulatory Surgery Centers ratings of outpatient surgical centers....

at 00:00
Butterfly Play LLC is dedicated to enhancing the mental and emotional development of children through personalized play skill...

at 00:00
Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company's IND-stage activities for ANS-858....



News published on and distributed by: